baber/WOPTO huggingface dataset:
Patent EP-0611801-B1 (EP)
Inventor: GIACOBBE JAMES
IPC: B32B27/08
Filed: 1994-02-16
Granted: 1997-07-30
Abstract: A film or sheet material 95-60 wt. % heteroplastic olefin polymer compsn. (I) and 5-40 wt. % of an ethylene alpha-olefin copolymer (II) of density 0.890-0.940 g/cc in which the alpha-olefin is of formula CH2=CHR (R = 1-8C alkyl). The heteroplastic olefin polymer compsn. (I) comprises 10-50 wt. % propylene polymer (III), 5-20 wt. % semi-crystalline linear copolymer fraction (IV) and 40-80 wt. % xylene-soluble copolymer fraction (V). (III) has an isotactic index greater than 80 and is propylene homopolymer or a copolymer contg. over 80 wt. % propylene with ethylene and/or a 4-10C alpha-olefin. (IV) has a crystallinity of 20-60 % and is insoluble in xylene at room temp. (IV) is a copolymer of ethylene and propylene contg. over 55 wt. % ethylene, or a copolymer of ethylene, propylene and 1-10 wt. % 4-10C alpha-olefin in which the combined content of ethylene and 4-10C alpha-olefin is over 55 wt. %, as a copolymer of ethylene and a 4-10C alpha olefin contg. over 55 wt. % 4-10C alpha-olefin. (V) has a intrinsic viscosity of 1.5-4.0 dl/g and is a copolymer of ethylene and propylene contg. 20-40 wt. % ethylene at a copolymer of ethylene, propylene and 1-10 wt. % 4-10C alpha-olefin in which the combined content of ethylene and 4-10C alpha-olefin is 20-40 wt. % or a copolymer of ethylene, 4-10C alpha-olefin and opt. 0.5-10 wt. %, diene, in which the 4-10C alpha-olefin content is 20-40 wt. %. The wt. ratio of (IV):(V) is less than 0.4:1. (I) is prepd. by polymerisation in at least 2 stages.
Patent EP-0618234-B1 (EP)
Inventor: UNGARELLI FABRIZIO
IPC: C08B37/10
Filed: 1994-03-18
Granted: 1997-06-04
Abstract: A process for the synthesis of semi-synthetic glycosaminoglycans of general formula III <CHEM> with heparin or heparan structure modified in position 2 of the alpha -L-iduronic-2-O-sulfate acid in which the sulfate group is, entirely or in part, substituted with a nucleophilic radical is described. Said process is carried out by treating glycosaminoglycans with heparin or heparan structure by means of a nucleophilic agent in alkaline medium.
Patent EP-0630971-B1 (EP)
Inventor: PUROHIT ASHOK PURUSHOTTM
IPC: C12Q1/68
Filed: 1994-06-13
Granted: 2001-04-18
Abstract: Disclosed are methods, reagents and kits for detecting Neisseria gonorrhoeae, as well as methods, reagents and kits for detecting Neisseria gonorrhoeae and/or Chlamydia trachomatis, in fluid samples, using primers and probes specific for each bacterial species.
Patent EP-0636903-B1 (EP)
Inventor: YOSHIDA MASATO
IPC: G01S7/497
Filed: 1994-07-25
Granted: 1998-10-07
Abstract: A safe distance measuring device employing an electromagnetic wave is provided. A laser diode (2) is energized to emit laser beams by a laser diode drive circuit (3) in accordance with a clock signal generated by a control circuit (29). The emitted laser beams are sequentially changed to predetermined scanning directions by a scanner (1) associated with control circuit (29). The scanned laser beams from scanner (1) are reflected by an object (19) to be received by a photodiode (5). An output of the photodiode is applied to control circuit (29) through a light receiving circuit (6) where an elapsed time from emission to receipt is computed to obtain a distance from scanner (1) to object (19). Based on data relating to scanning directions by a scanning position detector (4), a begin-and-end detecting circuit (28) can stop the radiation of electromagnetic waves around a scanning start point and a scanning end point which is danger to human bodies. <IMAGE>
Patent EP-0611192-B1 (EP)
Inventor: CHOPIN THIERRY
IPC: C01G25/00
Filed: 1994-02-04
Granted: 1998-06-10
Abstract: The invention relates to a process for obtaining compositions based on mixed oxides of zirconium and cerium which have high specific surfaces and are thermally stable, the said process being characterised in that it comprises the following stages: (i) a zirconium sol, on the one hand, and a cerium sol, on the other hand, are mixed in the stoichiometric proportions corresponding to those of the desired final composition, the ratio r of the mean diameter r1 of the particles constituting the zirconium sol to the diameter r2 of the particles constituting the cerium sol being at least 5, (ii) the mixture thus obtained is then dried by atomisation and finally (iv) the dried product is calcined. The invention also relates to the use of the compositions thus obtained as, or for the manufacture of, catalysts and/or catalyst supports, in particular in the field of automobile afterburning.
Patent EP-0628757-B1 (EP)
Inventor: DUTHEIL DANIEL
IPC: F16K21/10
Filed: 1994-05-27
Granted: 1998-01-28
Abstract: Assembly device with improved tamper proofing for a tap which closes after a time delay including a body (1) made as a single part, into which is fitted a cartridge (3) which groups together all the elements necessary for operation, characterised in that the body has, at its upper part, a skirt including a slide (10) which has a hole (9) the axis of which can coincide with that of the member (8 or 19) for fastening the push button (5) onto the end of the valve stem (4), the said hole normally being concealed by the upper part of the body (1) when the tap is being used. <IMAGE>
Patent EP-0633317-B1 (EP)
Inventor: ATANASSOVA ROSSITZA
IPC: C12N15/29
Filed: 1994-06-23
Granted: 2005-03-23
Abstract: 1) Chimeric gene for plant transformation. 2) It comprises at least, in the direction of transcription, a promoter region, a transgene and a termination region, characterised in that the termination region consists of at least one termination region of a plant histone gene which permits the expression of the protein in the regions of rapid growth. 3) Production of transgenic plants.
Patent EP-0674635-B1 (EP)
Title: Derives de quinuclidine comme inhibiteurs de la squalene synthetase
Inventor: BROWN GEORGE ROBERT
IPC: C07D453/02
Filed: 1993-12-21
Granted: 2001-03-28
Abstract: L'invention concerne les composés de la formule (I). Dans cette formule: R1 est un hydrogène ou un hydroxy; R2 est un hydrogène; ou R1 et R2 sont réunis ensemble pour que CR1-CR2 soit une double liaison; Ar1 est un groupe phénylène et Ar2 est un groupe hétéroclyclique; ou Ar1 est un groupe hétérocyclique et Ar2 est un groupe phényle; l'un ou l'autre d'entre Ar?1 et Ar2¿ ou les deux à la fois pouvant porter un ou plusieurs substituants choisis d'une manière indépendante parmi: halogéno, hydroxy, amino, nitro, cyano, carboxy, carbamoyle, (1-6C)alkyle, (2-6C)alcényle, (2-6C)alcynyle, (1-6C)alcoxy, (1-6C)alkylamino, di-[(1-6C)alkyl]amino N-(1-6C)alkylcarbamoyle, di-N,N-[(1-6C)alkyl]carbamoyle, (1-6C)alcoxycarbonyle, (1-6C)alkylthio, (1-6C)alkylsulinyle, (1-6C)alkylsulonyle, halogéno(1-6C)alkyle, (1-6C)alcanoylamino, uréido, N'-(1-6C)alkyluréido, (1-6C)alcanoyle et leurs dérivés oxime, ainsi que les O-(1-6C)alkyléthers desdits dérivés oxime; les conditions à satisfaire étant que Ar2 ne doit pas être un groupe hétéroaryle à 6 éléments contenant un ou deux atomes d'azote et, lorsque Ar?1 et Ar2¿ sont tous deux un hydrogène, Ar2 ne doit pas être un groupe oxadiazole. Ces composés et leurs sels acceptables sur le plan pharmaceutique sont des inhibiteurs de la squalène synthétase et ils sont donc utiles pour le traitement médical de troubles où un abaissement du cholestérol est bénéfique. On décrit également des procédés pour préparer ces dérivés, des compositions pharmaceutiques les contenant, ainsi que leur utilisation en médecine.
Patent EP-0698114-B1 (EP)
Inventor: NILSSON KURT G I
IPC: C12P19/26
Filed: 1994-05-17
Granted: 2002-12-04
Abstract: Synthesis of an amino-disaccharide, amino-oligosaccharide or a derivative thereof, characterized in that a monosaccharide, a disaccharide, an oligosaccharide, a glycoside or a derivative thereof, in the presence of a glycosidase as catalyst, is reacted with an amino-deoxy-saccharide or a derivative thereof, and that the amino-saccharide is isolated from the product mixture directly or after chemical/enzymatic modification.
Patent EP-0699194-B1 (EP)
Inventor: KING FRANCIS DAVID
IPC: A61K31/4427
Filed: 1994-05-16
Granted: 2006-11-29
Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof, and the use of a compound of formula (I) or a pharmaceutically acceptable salt thereof: <?in-line-formulae description="In-line Formulae" end="lead"?>X-CO-CH<SUB>2</SUB>-Z <?in-line-formulae description="In-line Formulae" end="tail"?> wherein X is a monocyclic or polycyclic aromatic group, Z is of sub-formula (h), (j) or (k): wherein n<SUP>1 </SUP>is 1, 2, 3 or 4; n<SUP>2 </SUP>is 0, 1, 2, 3 or 4; n<SUP>3</SUP>is 2, 3, 4 or 5; q is 0, 1, 2 or 3; p is 0, 1 or 2; m is 0, 1 or 2; R<SUB>5 </SUB>is hydrogen, C<SUB>1-2 </SUB>alkyl, aralkyl or R<SUB>5 </SUB>is (CH<SUB>2</SUB>)<SUB>z</SUB>-R<SUB>10 </SUB>wherein z is 2 or 3 and R<SUB>10 </SUB>is selected from cyano, hydroxyl, C<SUB>1-6 </SUB>alkoxy, phenoxy, C(O)C<SUB>1-6 </SUB>alkyl, COC<SUB>6</SUB>H<SUB>5</SUB>, -CONR<SUB>11</SUB>R<SUB>12</SUB>, NR<SUB>11</SUB>COR<SUB>12</SUB>, SO<SUB>2</SUB>NR<SUB>11</SUB>R<SUB>12 </SUB>or NR<SUB>11</SUB>SO<SUB>2</SUB>R<SUB>12 </SUB>wherein R<SUB>11 </SUB>and R<SUB>12 </SUB>are hydrogen or C<SUB>1-6 </SUB>alkyl; or R<SUB>5 </SUB>is straight or branched chain alkylene of chain length 1-6 carbon atoms terminally substituted by aryl, 3 to 8 membered cycloalkyl, 3 to 8 membered heterocyclyl, 5 or 6 membered monocyclic heteroaryl or 9 or 10 membered fused bicyclic heteroaryl linked through carbon, C<SUB>2-7 </SUB>alkoxycarbonyl, or secondary or tertiary hydroxy substituted C<SUB>1-6 </SUB>alkyl; ; and R<SUB>6</SUB>, R<SUB>7 </SUB>and R<SUB>8 </SUB>are independently hydrogen or C<SUB>1-6 </SUB>alkyl; and R<SUB>9 </SUB>is hydrogen or C<SUB>1-10</SUB>alkyl; and their use as pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and CNS disorders.
Patent EP-0702563-B1 (EP)
Inventor: NACY CAROL A
IPC: A61K38/22
Filed: 1994-05-26
Granted: 2003-08-06
Abstract: The present invention encompasses methods for reducing or inhibiting growth factor in cancer cells and tissues. More particularly immunogenic growth factor-containing compositions are administered to a human or animal with a cancer or tumor. The immunogenic compositions elicit the production of antibodies specific for growth factor which reduce the level of circulating growth factor, thus reducing or eliminating the proliferation of cancer. The present invention encompasses growth factor-containing liposomes and vesicles having portions of growth factor externally presented on their surfaces. The present invention also includes antibodies specific for growth factor. Thus, according to the present invention, growth factor levels are reduced either by active immunization of an individual using immunogenic growth factor-containing compositions or by passive immunization via administering to the individual an antibody or a group of antibodies specific for growth factor.
Patent EP-0705281-B1 (EP)
Inventor: BURKHARDT TERRY JOHN
IPC: C08F10/00
Filed: 1994-05-20
Granted: 1998-03-11
Abstract: L'invention concerne des systèmes de catalyseur à base d'alliage organométallique sur support éventuellement prépolymérisés à l'aide d'un monomère oléfinique, de préférence de l'éthylène ou du propylène, utile dans la polymérisation du propylène en vue d'obtenir du polypropylène isotactique. Ledit polypropylène isotactique présente une masse moléculaire d'environ 100000 g/m ou plus, un point de fusion d'environ 140 °C ou plus, et une morphologie granulaire. Le système de catalyseur à support présente généralement une activité catalytique élevée et, lorsqu'il est utilisé dans un réacteur de polymérisation, participe à un processus générant un faible encrassement du réacteur, une formation réduite de fines et de fragments.
Patent EP-0670098-B1 (EP)
Inventor: JOLMA PETRI
IPC: H04B1/707
Filed: 1994-09-19
Granted: 1999-05-12
Abstract: PCT No. PCT/FI94/00415 Sec. 371 Date May 22, 1995 Sec. 102(e) Date May 22, 1995 PCT Filed Sep. 19, 1994 PCT Pub. No. WO95/08901 PCT Pub. Date Mar. 30, 1995A mobile station, and a method for making a handover in a CDMA cellular radio system, which includes in each cell at least one base station connected to the mobile stations in the cell. The connection includes both a traffic channel and one or more control channels. The transmissions of the base stations are not synchronized with each other. A mobile station, after having established a simultaneous connection with two or more of the base stations while making a handover, transmits to the base stations using the same spreading code. The signals received by the base stations are combined in a base station controller, or the like. The base stations with which the mobile station communicates simultaneously, transmit to the mobile station each using a different spreading code. The mobile station receives and demodulates each of the signals, transmitted with different spreading codes, by a different rake receiving unit independent of the other units, each receiving unit being synchronized with the signal from the base station it is receiving. The mobile station combines the signals it has received from the base stations and demodulated by using its plural rake receiving units.
Patent EP-0725837-B1 (EP)
Inventor: KERN ANDREA
IPC: C07K14/015
Filed: 1994-10-28
Granted: 2000-01-12
Abstract: The present invention relates to a method of detecting a causative agent of the so-called spontaneous early abortion by investigating patients' samples for the presence of adeno-associated virias DNA (AAV DNA), or AAV antigen or antibodies, preferably of the IgM type, directed to AAV. Furthermore, the present invention relates to antibodies suitable for said method.
Patent EP-0765987-B1 (EP)
Inventor: KRUSE GERALD
IPC: E05G1/00
Filed: 1995-09-27
Granted: 1998-11-18
Abstract: The safe has a fixed column-shaped housing (4) from which moves the storage container (11) out of the top end surface. The movement of the storage container is supported by compression springs (10). The storage container is raised along guide bars belonging to the housing and at the same time guiding the compression springs. The guide bars also act as screws for shutting the lid (3) on the top end surface of the column-shaped housing. The lid has an opening for the cylindrical storage container.
Patent EP-0707809-B1 (EP)
Inventor: DIEKMANN BERND DIPL-ING
IPC: A47B17/00
Filed: 1995-10-20
Granted: 2001-11-14
Abstract: The rail, esp. for a work-table frame, contains one or more undercut lengthwise grooves (2). A face (4) on the adaptor (3) bears against the rail, the adaptor also having an extension (5) and a tapped bore (10), both at right angles to this face. A clamping screw (9) engaging in the bore has a block (8) turning on its free end and engaging in the adjacent undercut groove. In the unclamped position, the block is accommodated in a recess (7) in the adaptor and which is open to the face (4). There can be a hook (6) on the free end of the extension, parallel to the face (4) and engaging in an adjacent lengthwise groove in the rail.
Patent EP-0686703-B1 (EP)
Inventor: BERNARD JOHANNES GELEIJN
IPC: C22B19/04
Filed: 1995-05-24
Granted: 2001-02-21
Abstract: A method making pig iron employs an in-bath direct reduction performed in a metallurgical vessel (4) which has above it a melting cyclone (1) in which iron-oxide-containing material fed thereinto is pre-reduced by hot reducing gas coming from the vessel (4). Molten material passes downwardly from the melting cyclone (1) into the vessel (4). In order to recover zinc from a dust containing zinc and/or zinc oxide, the dust is fed into the melting cyclone. Zinc is allowed to vaporize out of the dust into the hot gas in the melting cyclone. The hot gas containing zinc is discharged from the melting cyclone, and zinc-containing material is extracted from this hot gas.   <IMAGE>
Patent EP-0667628-B1 (EP)
Inventor: LACAZE ALAIN
IPC: H02H7/00
Filed: 1995-02-13
Granted: 1997-03-26
Abstract: The coil includes a superconducting conductor (1) consisting of a number of strands (2) wound in order to form successive layers of the coil (3). Insulating layers (4) are arranged between each layer of the superconducting material. Each strand of the semiconductor does not have an insulating sleeve. A short circuit layer is provided between each winding and the corresponding insulation layer on which it is wound.
Patent EP-0687165-B1 (EP)
Inventor: HOERMANSDOERFER GERD
IPC: A61F2/30
Filed: 1994-12-28
Granted: 2000-08-23
Abstract: PCT No. PCT/DE94/01551 Sec. 371 Date Sep. 5, 1996 Sec. 102(e) Date Sep. 5, 1996 PCT Filed Dec. 28, 1994 PCT Pub. No. WO95/18586 PCT Pub. Date Jul. 13, 1995A process for producing threads by metal cutting when a more or less gradual change of the thread profile is desired in at least one of its sections. When producing a thread by turning, by milling or by turning and milling, the thread is cut in at least two successive operations with at least two different thread pitches and/or an offset value or a continuously changing pitch. The process is preferred for making possible a gradual change in the height and shape of the teeth or, as the case may be, the design of the thread bottom of a self-cutting thread to be progressively adapted to the curved outer profile of an artificial hip-joint socket.
Patent EP-0804245-B1 (EP)
Title: Collagen preparation for the controlled release of active substances
Inventor: ROREGER MICHAEL
IPC: A61K9/26
Filed: 1995-04-15
Granted: 1999-05-26
Abstract: A collagen preparation for the controlled release of active substances is characterized in that it has mixtures of acid-insoluble collagens with different molecular weight distributions.
Patent EP-0772767-B1 (EP)
Title: Device for testing the porosity of thin rubber products
Inventor: GRIEBEL ROBERT
IPC: G01N15/08
Filed: 1995-07-20
Granted: 1998-02-18
Abstract: PCT No. PCT/DE95/00971 Sec. 371 Date Mar. 26, 1997 Sec. 102(e) Date Mar. 26, 1997 PCT Filed Jul. 20, 1995 PCT Pub. No. WO96/03635 PCT Pub. Date Feb. 8, 1996Proposed is a device for testing the porosity of dielectric foil, particularly rubber products, such as condoms (2) with a cover holder over which the rubber product is placed, and of one or more outer electrodes (5), whereby the cover holder (1) and the outer electrodes (5) are connected to a source of voltage and an electrical gauge, whereby the outer electrodes (5) are in the form of points and the outer electrodes (5) and the cover holder (1) are relatively moveable toward one another so that the skin of the rubber product can gradually be scanned by the outer electrodes (5), and the gauge measures the flow of current in each electrode and by this measurement corresponds to the electrode in a reference measurement for the state in which there is an absence of material without the application of a rubber product, thereby showing a defect.
Patent EP-0735029-B1 (EP)
Inventor: MURAMOTO HIROKI
IPC: C07D277/64
Filed: 1996-03-28
Granted: 1998-06-03
Abstract: The object of the present invention is to provide novel benzothiazole derivatives and pharmaceutically acceptable salts thereof, which have a lipid lowering activity and are useful as a medicine. The compounds of the present invention and pharmaceutically acceptable salts thereof are represented by the following formula (I): <CHEM>  wherein     R1 is halogen, alkyl, trifluoromethyl, acetamide or -OX1;   X1 is hydrogen, alkyl or acyl; R2 is hydrogen, halogen, alkyl, hydroxyalkyl, trifluoromethyl, nitro, amino which may be substituted with alkyl or acyl, carboxy which may be esterified with alkyl, or -OX2; X2 is hydrogen, alkyl, acyl, carboxyalkyl which may be esterified with alkyl; or n is an integer from 1 to 3 which means a number of substituent R2; and plural R2 may be the same or different when n is 2 or 3; with the proviso that R1 is a group other than chloride when R2 is hydrogen.   The benzothiazole derivatives of the present invention have excellent pharmacological activities which significantly decrease cholesterol, triglyceride and low-density lipoprotein in blood. Therefore, they are novel compounds which are very useful as medicines such as a remedy for hyperlipemia.
Patent EP-0749710-B1 (EP)
Inventor: MACK KARL
IPC: B25H1/20
Filed: 1996-06-19
Granted: 2000-03-22
Abstract: A work table (1) for a medical or dental laboratory has a guide rod (12) below the table (2) to adjust the work surface (7), the rod adopting an in-use and a not-in-use position. It has a horizontal arm below the table, pivoted to it about a horizonal transverse axis (17a) at the rear plus a guide element at the front. The guide element (24) slides in a path (14) which stretches horizontally (14a) from the rear forwards and then upwards (14b) in a curve. The arm is telescopic between the pivot axis and the guide element or is guided in sliding fashion into a horizontal extension (13, 16) at the rear.
Patent EP-0737787-B1 (EP)
Inventor: THOOFT HENDRIK
IPC: E04C5/01
Filed: 1996-03-21
Granted: 1999-06-16
Abstract: A method for producing a continuous floor slab construction for industrial floors. An initial layer of stabilized sand material is first laid down on solid ground. Then a quantity of stone material is spread over this initial layer and pressed into the initial layer so that after hardening of the stabilized sand a rough surface is formed with this stone material. Finally, a concrete with 25 to 50 kg/m<3> of steel reinforcement fibers mixed into it is poured over this rough surface and finished to form a continuous concrete floor slab without sawed contraction joints and with a surface area of at least 500 m<2>. The invention also relates to a floor slab construction thus produced.
Patent EP-0780129-B1 (EP)
Inventor: YAMADA HAJIME
IPC: A61K47/40
Filed: 1996-04-10
Granted: 2005-03-16
Abstract: The present invention provides an external therapeutic composition for dermatitis comprising an aqueous solution including a therapeutically effective amount of an adrenal cortical steroid, a cyclodextrin, polysaccharides, and a carrier such as water, prepared by clathrating the adrenal cortical steroid in the cyclodextrin using a homomixer to form a clathrate, and adding the clathrate to an aqueous solution of polysaccharides, while being stirred uniformly, to dissolve the clathrate in the aqueous solution, as well as a method for the treatment of dermatitis in a mammalian subject, which comprises administering to said subject a therapeupically effective amount of the external therapeutic composition for dermatitis described above. The external therapeutic composition for dermatitis according to the present invention is extremely safe and can cure dermatitis such as an atopic dermatitis or the like without side effects.
Patent EP-0753269-B1 (EP)
Inventor: MARMONIER GILLES
IPC: A63C10/14
Filed: 1996-07-02
Granted: 1999-09-15
Abstract: The boot has a supple boot (2) with a leg (5) and a sole (4). This has a transversal slot (7), under the arch of the foot. A stud under the sole cooperates with a binding on the board. A rigid stirrup (4) passes through the slot and goes up on either side of the leg and is inclined backwards. A back part (15) surrounds the back of the leg and its base (17) is articulated on the stirrup, at the level of the ankles and its inclination backwards is limited. The stud is on the lower surface of the stirrup.